LVS - ISO/TC 85/SC 2

Projekta Nr.	ISO 20553:2025
Nosaukums	<p class="MsoBodyText"><span lang="FR" style="mso-ansi-language: FR;">Le présent document décrit les exigences minimales permettant d’établir des programmes de surveillance des travailleurs exposés à un risque de contamination interne par des substances radioactives, et établit des principes pour le développement de finalités et d’exigences compatibles avec les programmes de surveillance.</span></p> <p class="MsoBodyText"><span lang="EN-GB">Le présent document spécifie:</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">a)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les objectifs de la surveillance et des programmes de surveillance;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">b)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">la description des différentes catégories des programmes de surveillance;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">c)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les critères quantitatifs pour la conduite des programmes de surveillance;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">d)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les méthodes de surveillance appropriées et les critères de sélection;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">e)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les informations à collecter pour la conception d’un programme de surveillance;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">f)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les exigences générales pour les programmes de surveillance (par exemple, limite de détection, incertitudes tolérées);</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">g)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les fréquences des mesurages calculées en se basant sur la série de rapports de la CIPR «Occupational Intakes of Radionuclides (OIR)»;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">h)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">la surveillance individuelle dans certains cas (incorporation d’actinides, incorporation par plaie et incorporation à travers la peau intacte);</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="EN-GB" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria;"><span style="mso-list: Ignore;">i)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="EN-GB">l’assurance qualité;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">j)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">la documentation, la transmission et l’archivage des résultats.</span></p> <p class="MsoBodyText"><span lang="FR" style="mso-ansi-language: FR;">Le présent document ne s’applique pas:</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">à la surveillance de l’exposition au radon et à ses produits de filiation radioactifs;</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">aux descriptions détaillées des méthodes et des techniques de mesurage;</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">aux modes opératoires détaillés pour les mesurages in vivo et les analyses in vitro;</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">à l’interprétation des résultats de mesure en termes de doses;</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">aux données biocinétiques et aux modèles mathématiques pour convertir les activités mesurées en dose absorbée, en dose équivalente et en dose efficace;</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">à l’investigation des causes ou des implications d’une exposition ou d’une incorporation.</span></p>
Reģistrācijas numurs (WIID)	78759
Darbības sfēra	<p class="MsoBodyText"><span lang="FR" style="mso-ansi-language: FR;">Le présent document décrit les exigences minimales permettant d’établir des programmes de surveillance des travailleurs exposés à un risque de contamination interne par des substances radioactives, et établit des principes pour le développement de finalités et d’exigences compatibles avec les programmes de surveillance.</span></p> <p class="MsoBodyText"><span lang="EN-GB">Le présent document spécifie:</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">a)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les objectifs de la surveillance et des programmes de surveillance;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">b)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">la description des différentes catégories des programmes de surveillance;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">c)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les critères quantitatifs pour la conduite des programmes de surveillance;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">d)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les méthodes de surveillance appropriées et les critères de sélection;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">e)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les informations à collecter pour la conception d’un programme de surveillance;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">f)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les exigences générales pour les programmes de surveillance (par exemple, limite de détection, incertitudes tolérées);</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">g)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">les fréquences des mesurages calculées en se basant sur la série de rapports de la CIPR «Occupational Intakes of Radionuclides (OIR)»;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">h)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">la surveillance individuelle dans certains cas (incorporation d’actinides, incorporation par plaie et incorporation à travers la peau intacte);</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="EN-GB" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria;"><span style="mso-list: Ignore;">i)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="EN-GB">l’assurance qualité;</span></p> <p class="ListNumber1" style="mso-list: l1 level1 lfo2;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">j)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">la documentation, la transmission et l’archivage des résultats.</span></p> <p class="MsoBodyText"><span lang="FR" style="mso-ansi-language: FR;">Le présent document ne s’applique pas:</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">à la surveillance de l’exposition au radon et à ses produits de filiation radioactifs;</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">aux descriptions détaillées des méthodes et des techniques de mesurage;</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">aux modes opératoires détaillés pour les mesurages in vivo et les analyses in vitro;</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">à l’interprétation des résultats de mesure en termes de doses;</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">aux données biocinétiques et aux modèles mathématiques pour convertir les activités mesurées en dose absorbée, en dose équivalente et en dose efficace;</span></p> <p class="ListContinue1" style="mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="FR" style="mso-fareast-font-family: Cambria; mso-bidi-font-family: Cambria; mso-ansi-language: FR;"><span style="mso-list: Ignore;">—<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="FR" style="mso-ansi-language: FR;">à l’investigation des causes ou des implications d’une exposition ou d’une incorporation.</span></p>
Statuss	Standarts spēkā
ICS grupa	13.280

Sazināties ar mums

Sistēmas ziņojumi

ISO/TC 85/SC 2